Exelixis Inc [EXEL] stock is trading at $37.04, up 1.79%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EXEL shares have gain 0.08% over the last week, with a monthly amount drifted -3.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on February 24, 2025, when Wells Fargo downgraded its rating to a Equal Weight but kept the price target unchanged to $36 for it. Previously, Morgan Stanley upgraded its rating to Overweight on January 27, 2025, and elevated its price target to $40. On January 24, 2025, downgrade downgraded it’s rating to Perform. BMO Capital Markets downgraded its rating to a Market Perform and increased its price target to $40 on December 20, 2024. BofA Securities downgraded its rating to a Neutral and raised its price target to $39 on December 17, 2024. RBC Capital Mkts reiterated a Outperform rating for this stock on October 16, 2024, and upped its price target to $34. In a note dated September 19, 2024, UBS initiated an Neutral rating and provided a target price of $30 on this stock.
Exelixis Inc [EXEL] stock has fluctuated between $20.14 and $40.02 over the past year. Currently, Wall Street analysts expect the stock to reach $34.12 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $37.04 at the most recent close of the market. An investor can expect a potential drop of -7.88% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Exelixis Inc [NASDAQ:EXEL] reported sales of 2.17B for the trailing twelve months, which represents a growth of 18.16%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.28%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.24 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.19 points at the first support level, and at 35.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.51, and for the 2nd resistance point, it is at 37.99.
Ratios To Look Out For
For context, Exelixis Inc’s Current Ratio is 3.63. Further, the Quick Ratio stands at 3.58, while the Cash Ratio is 0.54. Considering the valuation of this stock, the price to sales ratio is 4.78, the price to book ratio is 4.65 and price to earnings (TTM) ratio is 20.90.
Transactions by insiders
Recent insider trading involved Haley Patrick J., EVP, Commercial, that happened on Mar 03 ’25 when 10000.0 shares were sold. Officer, PATRICK JOSEPH HALEY completed a deal on Mar 03 ’25 to buy 10000.0 shares. Meanwhile, Director Smith Julie sold 54514.0 shares on Feb 27 ’25.
